Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Status:
Completed
Trial end date:
2017-10-17
Target enrollment:
Participant gender:
Summary
This study is designed to demonstrate the safety and tolerability of suprachoroidal CLS-TA
alone or in combination with intravitreal aflibercept in subjects with diabetic macular edema
associated with diabetes mellitus.